The downgrade from Buy to Hold suggests that Truist Securities sees limited upside potential or increased risk in OrthoPediatrics' stock. The reduction in the price target further implies a bearish outlook on the stock's value, which could lead to a negative short-term impact on the stock price as market sentiment adjusts to the new analyst rating and price target.